Vitamin D Research
back to research menu
Endometrial Cancer
- Calcium, vitamin D and cancer. Anticancer Res. 2009 Sep;29(9):3687–98. Review.
- Current impediments to acceptance of the ultraviolet-B-vitamin D-cancer hypothesis. Anticancer Res. 2009 Sep;29(9):3597–604. Review.
- A population-based cohort study on sun habits and endometrial cancer. Br J Cancer. 2009 Aug 4;101(3):537–40.
- Retiform uterine tumours resembling ovarian sex cord tumours. A comparative immunohistochemical study with retiform structures of the female genital tract. Histopathology. 2009 Mar;54(4):471–7.
- Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts. Arch Intern Med. 2009 Feb 9;169(3):294–304.
- Uterine involvement of malignant mesothelioma detected by analyses of cervicovaginal smear and endometrial biopsy specimens. Diagn Cytopathol. 2009 Feb;37(2):150–3.
- Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study. J Clin Endocrinol Metab. 2008 Dec;93(12):4787–96.
- Vitamin D and calcium intake in relation to risk of endometrial cancer: a systematic review of the literature. Prev Med. 2008 Apr;46(4):298–302. Review.
- Bone loss in patients with breast cancer receiving aromatase inhibitors and associated treatment strategies. Cancer Treat Rev. 2008;34 Suppl 1:S31–42. Review.
- Vitamin D, ecologic studies and endometrial cancer. Prev Med. 2007 Nov;45(5):323–4.
- Is ultraviolet B irradiance inversely associated with incidence rates of endometrial cancer: an ecological study of 107 countries. Prev Med. 2007 Nov;45(5):327–31.
- Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor. Am J Surg Pathol. 2007 Sep;31(9):1378–86.
- Relative expression of 1,25-dihydroxyvitamin D3 receptor, vitamin D 1 alpha-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers. Reprod Sci. 2007 Jul;14(5):486–97.
- Expression of 25 hydroxyvitamin D3-1alpha-hydroxylase in human endometrial tissue. J Steroid Biochem Mol Biol. 2007 Mar;103(3–5):771–5.
- Vitamin D status and cancer: new insights. Curr Opin Clin Nutr Metab Care. 2007 Jan;10(1):6–11. Review.
- Calretinin: an immunohistochemical marker for the normal functional endometrial stroma and alterations of the immunoreactivity in dysfunctional uterine bleeding. Pathol Res Pract. 2007;203(2):79–83.
- Uterine tumors resembling ovarian sex cord tumors are polyphenotypic neoplasms with true sex cord differentiation. Mod Pathol. 2006 Jan;19(1):17–24.
- Dietary factors and endometrial cancer risk. Results of a case-control study in Mexico. Int J Gynecol Cancer. 2005 Sep–Oct;15(5):938–45.
- The DNA mismatch repair gene hMSH2 is a potent coactivator of oestrogen receptor alpha. Br J Cancer. 2005 Jun 20;92(12):2286–91.
- Involvement of suppressor for Gal 1 in the ubiquitin/proteasome-mediated degradation of estrogen receptors. J Biol Chem. 2004 Mar 26;279(13):12020–6.
- CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma. Histopathology. 2003 Aug;43(2):144–50.
- Uterine tumor resembling ovarian sex-cord tumor: report of a case mimicking cervical adenocarcinoma. Int J Gynecol Pathol. 2003 Jul;22(3):297–302.
- Inhibin is more specific than calretinin as an immunohistochemical marker for differentiating sarcomatoid granulosa cell tumour of the ovary from other spindle cell neoplasms. J Clin Pathol. 2003 Mar;56(3):221–4.
- Ecologic studies of solar UVB radiation and cancer mortality rates. Recent Results Cancer Res. 2003;164:371–7. Review.
- Role of estrogens in the management of postmenopausal bone loss. Rheum Dis Clin North Am. 2001 Feb;27(1):143–62. Review.
- Differential diagnosis of mesothelial and ovarian cancer cells in ascites by immunocytochemistry using Ber-EP4 and calretinin. Acta Cytol. 2000 May–Jun;44(3):485–8.
- Alternatives to hormone replacement therapy: raloxifene and tibolone. Z Arztl Fortbild Qualitatssich. 2000 Apr;94(3):205–9. Review.
- Selective estrogen receptor modulators (SERM): new substances for hormone replacement therapy. Schweiz Med Wochenschr. 1999 Dec 11;129(49):1926–30. Review.
- Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma. Mod Pathol. 1998 Oct;11(10):929–33.
- Osteoporosis in women: prevention and treatment. J Am Pharm Assoc (Wash). 1998 Sep–Oct;38(5):614–23; quiz 623–4. Review.
- Prevention and treatment of osteoporosis: does the future belong to hormone replacement therapy? J Clin Pharmacol. 1997 Dec;37(12):1087–99. Review.
- Calretinin. A selective marker of normal and neoplastic mesothelial cells in serous effusions. Acta Cytol. 1997 Nov–Dec;41(6):1757–61.
- The brittle bone: how to save women from osteoporosis. Int J Fertil Womens Med. 1997 Mar–Apr;42(2):101–6. Review.
- Vitamin D receptor in endometrial carcinoma and the differentiation-inducing effect of 1,25-dihydroxyvitamin D3 on endometrial carcinoma cell lines. J Obstet Gynaecol Res. 1996 Dec;22(6):529–39.
- Intake of selected micronutrients and the risk of endometrial carcinoma. Cancer. 1996 Mar 1;77(5):917–23.
- Postmenopausal hormone replacement therapy—clinical implications. J Hypertens. 1994 Apr;12(4):429–37. Review.
- Additive inhibition of RL95-2 endometrial carcinoma cell growth by carboplatin and 1,25 dihydroxyvitamin D3. Gynecol Oncol. 1993 Nov;51(2):155–9.
- Receptors for 1,25-dihydroxyvitamin D3 in gynecologic neoplasms. Gynecol Oncol. 1992 Feb;44(2):131–6.
- Fuller Albright. His concept of postmenopausal osteoporosis and what came of it. Clin Orthop Relat Res. 1991 Aug;(269):128–41.
- Responsiveness of human carcinoma cells of gynecologic origin to 1,25-dihydroxycholecalciferol. Am J Obstet Gynecol. 1986 Dec;155(6):1293–6.
- Pathogenesis and management of primary osteoporosis. Clin Pharm. 1986 Aug;5(8):639–59. Review.
- Current considerations of the menopause. Ann Clin Lab Sci. 1985 May–Jun;15(3):219–28.
- Hypercalcemia associated with gynecologic malignancies: biochemical characterization. Cancer. 1982 Jun 1;49(11):2389–94.
- Steroid hormone receptors. Vitam Horm. 1975;33:649–736.
back to research menu